Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MARIZYME, INC. (MRZM)
|
Add to portfolio |
|
|
|
| Price: |
$0.05
| | Metrics |
| OS: |
45.7
|
M
| |
-664
|
% ROE
|
| Market cap: |
$2.28
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
($1.16)
| |
|
|
|
BVPS
|
$0.16
| |
0.31
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.2 | 0.2 | 0.2 | 1.1 | 0.0 | 0.1 | 0.3 | 0.4 |
| Revenue growth | 11.0% | 6.7% | -81.4% | 5141.2% | -80.0% | -65.2% | -28.6% | -66.8% |
| Cost of goods sold | 0.1 | 0.1 | 0.1 | 1.1 | 0.0 | 0.1 | 0.2 | 0.2 |
| Gross profit | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 |
| Gross margin | 76.7% | 61.8% | 70.4% | 0.0% | 0.6% | 14.1% | 28.4% | 43.5% |
| Selling, general and administrative | | | | | | | 0.2 | |
| Research and development | 4.0 | 1.7 | | | | | | |
| General and administrative | 6.4 | 6.3 | 3.5 | 0.4 | 0.1 | 0.0 | | 0.9 |
| EBITA | -13.0 | -8.8 | -5.2 | -1.1 | -0.2 | 0.0 | -0.2 | -1.0 |
| EBITA margin | -5556.6% | -4195.1% | -2633.9% | -100.0% | -1224.2% | -34.9% | -62.5% | -235.6% |
| Amortization of intangibles | | | 0.6 | | | | | 0.2 |
| EBIT | -13.0 | -8.8 | -5.8 | -1.1 | -0.2 | 0.0 | -0.2 | -1.2 |
| EBIT margin | -5556.6% | -4195.1% | -2932.9% | -100.0% | -1224.2% | -34.9% | -62.5% | -292.0% |
| Pre-tax income | -38.2 | -11.0 | -5.8 | -1.1 | -0.2 | -0.6 | -0.9 | -9.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -38.2 | -11.0 | -5.8 | -1.1 | -0.2 | -0.6 | -0.9 | -9.0 |
| Net margin | -16346.2% | -5230.2% | -2965.0% | -100.0% | -1232.2% | -563.9% | -299.8% | -2219.2% |
| |
| Diluted EPS | ($0.94) | ($0.31) | ($0.22) | ($0.05) | ($0.04) | ($0.52) | ($0.03) | ($0.28) |
| Shares outstanding (diluted) | 40.7 | 36.0 | 26.4 | 19.8 | 6.7 | 1.1 | 32.3 | 31.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|